Programmed Death Ligand 1 (PD-L1) Expression in Surgically Resectable Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
D'Arcangelo, M. [1 ]
Puccetti, M. [2 ]
Bravaccini, S. [3 ]
D'Incecco, A. [4 ]
Ligorio, C. [5 ]
Terracciano, L. [6 ]
Damiani, S. [5 ]
Ravaioli, S. [3 ]
Tumedei, M. M. [3 ]
Bennati, C. [1 ]
Minuti, G. [1 ]
Vecchiarelli, S. [1 ]
Landi, L. [1 ]
Incarbone, M. [7 ]
Milesi, M. [7 ]
Cappuzzo, F. [1 ]
机构：
[1] Ausl Romagna, Oncol Hematol, Ravenna, Italy
[2] Ausl Romagna, Pathol, Ravenna, Italy
[3] IRST, Lab Biosci, Meldola, Italy
[4] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy
[5] Univ Bologna, Bologna, Italy
[6] Univ Hosp Basel, Basel, Switzerland
[7] Multimedica, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
NSCLC; Tumor grade; PD-L1;
D O I：
10.1016/j.jtho.2017.09.1937
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB074
引用
收藏
页码：S2390 / S2390
页数：1
相关论文
共 50 条
  • [41] Correlation Between Programmed Death-1 (PD-1) Expression in Tumor Infiltrating Lymphocytes and Programmed Death Ligand-1 (PD-L1) Expression in Non-Small Cell Lung Carcinoma
    Driver, Brandon
    Miller, Ross A.
    Deavers, Michael
    Tacha, David
    Bernicker, Eric
    Cagle, Philip T.
    LABORATORY INVESTIGATION, 2017, 97 : 475A - 475A
  • [42] Validation of the immunohistochemical expression of programmed death ligand 1 (PD-L1) on cytological smears in advanced non small cell lung cancer
    Capizzi, Elisa
    Ricci, Costantino
    Giunchi, Francesca
    Zagnoni, Stefano
    Ceccarelli, Claudio
    Gomez, Begona Urrios Alvarez
    Casolari, Laura
    Gelsomino, Francesco
    Trisolini, Rocco
    Fiorentino, Michelangelo
    Ardizzoni, Andrea
    LUNG CANCER, 2018, 126 : 9 - 14
  • [43] Association of PD-L1 expression with hotspot mutations in non-small cell lung cancer (NSCLC).
    Wan, Renping
    Zhang, Xiaoni
    Qu, Hongyue
    Li, Hui
    Li, Yingmei
    Xu, Mingyan
    Xiao, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [45] Clinicopathological and genomic correlates of programmed cell death ligand 1 (PD-L1) expression in nonsquamous non-small-cell lung cancer
    Lamberti, G.
    Spurr, L. F.
    Li, Y.
    Ricciuti, B.
    Recondo, G.
    Umeton, R.
    Nishino, M.
    Sholl, L. M.
    Meyerson, M. L.
    Cherniack, A. D.
    Awad, M. M.
    ANNALS OF ONCOLOGY, 2020, 31 (06) : 807 - 814
  • [46] High level of programmed death ligand 1 (PD-L1) predicts longer survival in patients with resectable small cell lung cancer
    Jing, Wang
    Wang, Shijiang
    Ding, Xiao
    Guo, Hongbo
    Li, Ji
    Wang, Haiyong
    Kong, Li
    Yu, Jinming
    Zhu, Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2675 - 2682
  • [47] Clinical correlation and frequency of programmed death ligand-1 (PD-L1) expression in EGFR-mutant and ALK-rearranged non-small cell lung cancer (NSCLC).
    Gainor, Justin F.
    Sequist, Lecia V.
    Shaw, Alice Tsang
    Azzoli, Christopher G.
    Piotrowska, Zofia
    Huynh, Tiffany
    Fulton, Linnea
    Schultz, Katherine
    Hata, Aaron N.
    Engelman, Jeffrey A.
    Mino-Kenudson, Mari
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] PD-L1 Immunohistochemistry as Biomarker in Non-Small Cell Lung Cancer (NSCLC)
    Krenbek, Dagmar
    Weidinger, Barbara
    Jarius, Christa
    Holzer, Sophia
    Fabican, Hannah
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Chott, Andreas
    Setinekl, Ulrike
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S430 - S430
  • [49] Immunohistochemical (IHC) scoring of programmed death-ligand 1 (PD-L1) protein expression in non-small cell lung cancer (NSCLC) using an automated digital pathology algorithm
    Miri, M. S.
    Marati, V.
    Inge, L.
    Jimenez, J.
    Chen, C.
    Zuiderveld, K.
    Hayden, D.
    Lopez, B.
    Luu, D.
    Ranger-Moore, J.
    Guetter, C.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S132 - S132
  • [50] Non-small cell lung cancers (NSCLC) and programmed death ligand 1 (PD-L1) testing: multicentric analysis of clinical, pathological and molecular features
    Elshiekh, M.
    Mani, A.
    Kitson, R.
    Josephides, E.
    Clifford, A.
    Desai, S.
    Gupta, N.
    Bowen, F.
    Berry, M.
    Bloch, S.
    Ross, C.
    Counihan, I.
    Anderson, J. R.
    Nandi, J.
    Roddie, M.
    Copley, S.
    Hatcher, O.
    Denton, A.
    Power, D.
    Lewanski, C.
    Newsom-Davis, T.
    Viola, P.
    LUNG CANCER, 2018, 115 : S52 - S53
12345